EBAY
50
-3
ABBV
51
-2
MSI
69
-3
CME
56
-3
AAL
47
-3
JPM
53
-2
SWN
70
3
NFLX
55
-3
QRVO
33
-3
MS
50
-8
HON
55
-4
M
14
2
WDC
49
-3
EQT
44
2
ETR
68
-3
GD
57
-2
CI
66
-2
NTAP
58
2
EMN
70
-2
FMC
36
3
EBAY
50
-3
ABBV
51
-2
MSI
69
-3
CME
56
-3
AAL
47
-3
JPM
53
-2
SWN
70
3
NFLX
55
-3
QRVO
33
-3
MS
50
-8
HON
55
-4
M
14
2
WDC
49
-3
EQT
44
2
ETR
68
-3
GD
57
-2
CI
66
-2
NTAP
58
2
EMN
70
-2
FMC
36
3
Financhill
Back

GraniteShares 2x Long NVDA Daily ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
43

NVDL
GraniteShares 2x Long NVDA Daily ETF

Last Price:
56.42
Seasonality Move:
13.9%
Buy
73

RYTM
Rhythm Pharmaceuticals

Last Price:
55.07
Seasonality Move:
11.04%
Sell
43
GraniteShares 2x Long NVDA Daily ETF (NVDL) is a Sell

Is GraniteShares 2x Long NVDA Daily ETF a Buy, Sell or Hold?

  • The current GraniteShares 2x Long NVDA Daily ETF [NVDL] share price is $51.17. The Score for NVDL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NVDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVDL Stock Price Chart

What is GraniteShares 2x Long NVDA Daily ETF's stock price today?

  • The GraniteShares 2x Long NVDA Daily ETF share price today is $51.17
    The current trend is relatively stagnant and NVDL is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $53.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

NVDL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.86 Sell
Relative Strength Index (14 RSI): 45.26 Sell
Chaikin Money Flow: -19347235 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.17 - 66.15) Sell
Bollinger Bands (100): (44.91 - 71.31) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.46 Buy
Relative Strength Index (14 RSI): 67.83 Buy
Chaikin Money Flow: -159819 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.64 - 50.28) Buy
Bollinger Bands (100): (39.46 - 48.56) Buy

NVDL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.42 Sell
20-day SMA: 55.87 Sell
50-day SMA: 58.1 Sell
200-day SMA: 42.99 Buy
8-day EMA: 52.81 Sell
20-day EMA: 54.29 Sell
50-day EMA: 56.76 Sell
200-day EMA: 45.65 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.55 Buy
20-day SMA: 48.38 Buy
50-day SMA: 47.86 Buy
200-day SMA: 43.39 Buy
8-day EMA: 50.8 Buy
20-day EMA: 49.06 Buy
50-day EMA: 47.17 Buy
200-day EMA: 41.51 Buy

GraniteShares 2x Long NVDA Daily ETF Earnings Growth & NVDL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.

GraniteShares 2x Long NVDA Daily ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):